348635 <common-name>N-[1-(butylamino)-3-[4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1-oxopropan-2-yl]-4-chlorobenzamide</common-name> <description>N-[1-(butylamino)-3-[4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1-oxopropan-2-yl]-4-chlorobenzamide is a chemical compound with the formula C28H39ClN4O3. With an average molecular weight of 515.10 g/mol, N-[1-(butylamino)-3-[4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1-oxopropan-2-yl]-4-chlorobenzamide is a heavy molecule.</description> <cas>57228-07-6</cas> <pubchem-id>42213</pubchem-id> <chemical-formula>C28H39ClN4O3</chemical-formula> <weight>515.1</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T12:43:50Z</created-at> <updated-at type="dateTime">2026-08-31T12:43:50Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCCCNC(=O)C(CC1=CC=C(C=C1)OCCCN2CCN(CC2)C)NC(=O)C3=CC=C(C=C3)Cl</moldb-smiles> <moldb-formula>C28H39ClN4O3</moldb-formula> <moldb-inchi>InChI=1S/C28H39ClN4O3/c1-3-4-14-30-28(35)26(31-27(34)23-8-10-24(29)11-9-23)21-22-6-12-25(13-7-22)36-20-5-15-33-18-16-32(2)17-19-33/h6-13,26H,3-5,14-21H2,1-2H3,(H,30,35)(H,31,34)</moldb-inchi> <moldb-inchikey>XOXCNBFVXCRYGV-UHFFFAOYSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">514.2710688</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>4.6</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM344528</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>N-[1-(butylamino)-3-[4-[3-(4-methylpiperazin-1-yl)propoxy]phenyl]-1-oxopropan-2-yl]-4-chlorobenzamide</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organic acids and derivatives</superklass> <klass>Carboxylic acids and derivatives</klass> <subklass>Amino acids, peptides, and analogues</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0298965</sync-id> <structure-inchikey>XOXCNBFVXCRYGV-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>4006000040000000002180000200040000000000000400000401008000000000000000000200020020000000000000000000000000000000000000000200000000000000000040040001000000000000002400100000010000020000800000000000002001008000000000400000000100000002010000000000000000000000002000004002000000020000000000408000000000000000000008000000000000000000000000000000000008400000000000100008000000a000000000000000000000000000000000800000000000400010004000800000000220000000010000000000000000000048000000010400000000000000000000020000000000</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJgAAAIABBgBgAAAAAQMGAGAAAAAC AgYAYAAAAAICBgBgAAAAAgIHAGgAAAADAgEGACgAAAADBAgAKAAAAAMCBgBg AAAAAwEGAGAAAAACAgZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBBkAoAAAA AwQGQGgAAAADAwEGQGgAAAADAwEIACgAAAADAgYAYAAAAAICBgBgAAAAAgIG AGAAAAACAgcAIAAAAAMGAGAAAAACAgYAYAAAAAICBwAgAAAAAwYAYAAAAAIC BgBgAAAAAgIGAGAAAAABAwcAaAAAAAMCAQYAKAAAAAMECAAoAAAAAwIGQCgA AAADBAZAaAAAAAMDAQZAaAAAAAMDAQZAKAAAAAMEBkBoAAAAAwMBBkBoAAAA AwMBEQAgAAAAAQsAAQABAgACAwADBAAEBSAFBigCBQcABwgACAkACQpoDAoL aAwLDGgMDA1oDA0OaAwMDyAPEAAQEQAREgASEwATFAAUFQAVFgAWFwAXGAAW GQAHGgAaGyAbHCgCGx0gHR5oDB4faAwfIGgMICFoDCEiaAwgIwAOCWgMGBMA Ih1oDEIDAAAABgoLDA0OCQYUFRYXGBMGHh8gISIdFwQAAAAAAAAAFg== </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:46:56Z</structure-indexed-at> </compound>